Breaking News Instant updates and real-time market news.

CELG

Celgene

$84.59

0.73 (0.87%)

15:48
07/10/18
07/10
15:48
07/10/18
15:48

Celgene raised prices on both Revlimid and Pomalyst by 5%, says Piper Jaffray

Piper Jaffray analyst Christopher Raymond noted that Wolters Kluwer Health reports that Celgene increased its prices for Revlimid and Pomalyst by 5%, effective yesterday. The analyst, who pointed out that this is the first increase since October 2017 for both drugs, said the price hikes should provide some tailwind to Celgene's second half results. He maintains his Neutral rating on Celgene shares.

  • 26

    Jul

CELG Celgene
$84.59

0.73 (0.87%)

06/28/18
PIPR
06/28/18
NO CHANGE
Target $55
PIPR
Overweight
Acceleron price target raised to $55 at Piper Jaffray after luspatercept data
Piper Jaffray analyst Edward Tenthoff raised his price target on Acceleron (XLRN) to $55 and kept his Overweight rating after the company's Phase 3 MEDALIST trial of luspatercept in myelodysplastic syndromes - MDS - met the primary and secondary endpoints. The analyst notes that the company, along with its partner Celgene (CELG) will now report full data at a medical conference this year and then file an NDA and MAA in the first half of next year. Tenthoff adds that today's results increase his confidence for luspatercept in lower-risk, front-line MDS.
06/29/18
JEFF
06/29/18
NO CHANGE
Target $115
JEFF
Buy
Luspatercep data could turn around negative Celgene sentiment, says Jefferies
Last night's positive Phase III data for luspatercep represents a $1B-$2B opportunity and could help turn around negative sentiment on Celgene, Jefferies analyst Michael Yee tells investors in a research note titled "Some Good News Helps Re-instill Some Confidence in Pipeline." The stock is "cheap and assumes nearly no pipeline at current levels," Yee contends. He sees "numerous key catalysts" in the second half of 2018 and keeps a Buy rating on Celgene with a $115 price target.
07/06/18
MSCO
07/06/18
NO CHANGE
MSCO
Morgan Stanley doesn't expect much movement in Celgene on settlement news
Morgan Stanley analyst Matthew Harrison noted that Celgene announced a settlement of ongoing Revlimid patent litigation with Accord Healthcare in the U.K., though he does not expect the stock to move much on this development given that most investors anticipated a generic version of the drug arriving in the EU by the early 2020s. Additionally, he believes investors are more heavily focused on Revlimid's intellectual property situation in the U.S. Harrison maintains his Equal Weight rating and $90 price target on Celgene shares.
07/10/18
PIPR
07/10/18
DOWNGRADE
Target $52
PIPR
Neutral
Acceleron downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff downgraded Acceleron Pharma (XLRN) to Neutral and lowered his price target for the shares to $52 from $55. Acceleron and partner Celgene (CELG) last night announced positive Phase III Believe results for luspatercept in transfusion dependent beta thalassemia, Tenthoff tells investors in a research note. The stock in premarket trading is up $6.10, or 13%, to $53.50. This is a nice second win for luspatercept, but Acceleron shares are not a buy at current valuation levels, the analyst contends. He believes luspatercept does not command the same market opportunity in beta thalassemia due to the expected approval of curative gene therapy by 2020. As such, Tenthoff lowered his penetration rates for luspatercept in beta thal to account for gene therapy competition. He says, however, that partner Celgene could acquire Acceleron, which presents a risk to his downgrade.

TODAY'S FREE FLY STORIES

HMNY

Helios and Matheson

$0.02

0.0001 (0.58%)

10:33
10/15/18
10/15
10:33
10/15/18
10:33
Hot Stocks
Helios and Matheson: Proxy firms recommend voting for reverse stock split »

Helios and Matheson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
10/15/18
10/15
10:30
10/15/18
10:30
Conference/Events
RBC Capital healthcare tech analyst to hold analyst/industry conference call »

Healthcare Technology…

PFE

Pfizer

$43.13

-0.65 (-1.48%)

10:30
10/15/18
10/15
10:30
10/15/18
10:30
Options
Pfizer call option buyers as shares slip »

Pfizer call option buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 07

    Nov

10:30
10/15/18
10/15
10:30
10/15/18
10:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

CAMP

CalAmp

$19.42

-0.02 (-0.10%)

, EB

Eventbrite

$27.95

-0.17 (-0.60%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

CAMP

CalAmp

$19.42

-0.02 (-0.10%)

EB

Eventbrite

$27.95

-0.17 (-0.60%)

XYF

X Financial

$9.10

-0.45 (-4.71%)

BSVN

Bank7

$18.47

0.35 (1.93%)

ELAN

Elanco

$31.90

-0.76 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PH

Parker-Hannifin

$163.81

-3.6 (-2.15%)

, ROK

Rockwell Automation

$170.00

-2.89 (-1.67%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

PH

Parker-Hannifin

$163.81

-3.6 (-2.15%)

ROK

Rockwell Automation

$170.00

-2.89 (-1.67%)

NTRI

Nutrisystem

$34.46

-2.66 (-7.17%)

KLAC

KLA-Tencor

$91.27

-1.91 (-2.05%)

DLPH

Delphi Technologies

$23.27

-0.09 (-0.39%)

MNST

Monster Beverage

$52.46

-0.83 (-1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$164.45

0.63 (0.38%)

, PNC

PNC Financial

$124.75

0.6 (0.48%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

MCD

McDonald's

$164.45

0.63 (0.38%)

PNC

PNC Financial

$124.75

0.6 (0.48%)

RL

Ralph Lauren

$124.99

3.5 (2.88%)

ATVI

Activision Blizzard

$75.00

-2.99 (-3.83%)

LULU

Lululemon

$144.33

0.63 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 06

    Nov

  • 16

    Jan

  • 12

    Apr

  • 17

    Jul

  • 16

    Oct

HMLP

Hoegh LNG Partners

$17.82

0.155 (0.88%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Hot Stocks
Breaking Hot Stocks news story on Hoegh LNG Partners 

Hoegh LNG trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$332.99

5.51 (1.68%)

10:26
10/15/18
10/15
10:26
10/15/18
10:26
Periodicals
Lockheed Martin's F-35 flights resume after examination, Reuters reports »

F-35 jets have resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

AMZN

Amazon.com

$1,747.72

-40.91 (-2.29%)

10:26
10/15/18
10/15
10:26
10/15/18
10:26
Technical Analysis
Technical Take: Amazon.com poised for a bounce »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

NBEV

New Age Beverages

$6.62

0.43 (6.95%)

10:25
10/15/18
10/15
10:25
10/15/18
10:25
Options
New Age Beverages call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
10/15/18
10/15
10:25
10/15/18
10:25
Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

IHRT

iHeartMedia

$0.00

(0.00%)

10:25
10/15/18
10/15
10:25
10/15/18
10:25
Conference/Events
Cowen TMT analyst Vitanza to hold an analyst/industry conference call »

Technology, Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

PBYI

Puma Biotechnology

$42.19

-0.5 (-1.17%)

, RHHBY

Roche

$0.00

(0.00%)

10:20
10/15/18
10/15
10:20
10/15/18
10:20
Recommendations
Puma Biotechnology, Roche analyst commentary  »

Roche breast cancer data…

PBYI

Puma Biotechnology

$42.19

-0.5 (-1.17%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

  • 07

    Nov

  • 24

    Dec

10:20
10/15/18
10/15
10:20
10/15/18
10:20
General news
The 0.5% U.S. August business inventory rise »

The 0.5% U.S. August…

10:18
10/15/18
10/15
10:18
10/15/18
10:18
Hot Stocks
Breaking Hot Stocks news story  »

Mercantil Bank Holding…

AAPL

Apple

$218.56

-3.54 (-1.59%)

10:18
10/15/18
10/15
10:18
10/15/18
10:18
Technical Analysis
Technical Take: Apple near session lows »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/15/18
10/15
10:17
10/15/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/15/18
10/15
10:16
10/15/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
10/15/18
10/15
10:15
10/15/18
10:15
General news
Treasury Action: yields remained easier »

Treasury Action: yields…

10:13
10/15/18
10/15
10:13
10/15/18
10:13
Hot Stocks
Breaking Hot Stocks news story  »

Mercantil Bank Holding…

ATVI

Activision Blizzard

$74.23

-3.76 (-4.82%)

10:13
10/15/18
10/15
10:13
10/15/18
10:13
Technical Analysis
Technical Take: Activision Blizzard bounces off low of the day »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$192.26

0.02 (0.01%)

10:10
10/15/18
10/15
10:10
10/15/18
10:10
Options
Home Depot calls active »

Home Depot calls active.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
10/15/18
10/15
10:10
10/15/18
10:10
General news
U.S. business inventories rose 0.5% with sales up 0.5% too in August »

U.S. business inventories…

CGC

Canopy Growth

$52.89

3.1 (6.23%)

10:05
10/15/18
10/15
10:05
10/15/18
10:05
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.